These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29694242)

  • 21. Endostar combined with chemotherapy for treatment of metastatic colorectal and gastric cancer: a pilot study.
    Zhou JF; Bai CM; Wang YZ; Li XY; Cheng YJ; Chen SC
    Chin Med J (Engl); 2011 Dec; 124(24):4299-303. PubMed ID: 22340403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endostar reduces the growth and metastasis by inhibiting angiogenesis and lymphangiogenesis in nude mouse models of human cervical cancer].
    Jia YT; Li ZX; Liu M; Chen SA; Zhang L; Wang YD
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):254-7. PubMed ID: 19615276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of efficacy and toxicity of bevacizumab, endostar and apatinib in transgenic and human lung cancer xenograftzebrafish model.
    Jin Y; Wei L; Jiang Q; Song X; Teng C; Fan C; Lv Y; Liu Y; Shen W; Li L; Huang D; Xin T
    Sci Rep; 2018 Oct; 8(1):15837. PubMed ID: 30367145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endostar, a modified endostatin inhibits non small cell lung cancer cell in vitro invasion through osteopontin-related mechanism.
    Ni Q; Ji H; Zhao Z; Fan X; Xu C
    Eur J Pharmacol; 2009 Jul; 614(1-3):1-6. PubMed ID: 19389394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging integrin α(v)β(3) positive glioma with a novel RGD dimer probe and the impact of antiangiogenic agent (Endostar) on its tumor uptake.
    Wu H; Chen H; Sun Y; Wan Y; Wang F; Jia B; Su X
    Cancer Lett; 2013 Jul; 335(1):75-80. PubMed ID: 23403076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endostar induces apoptotic effects in HUVECs through activation of caspase-3 and decrease of Bcl-2.
    Ling Y; Lu N; Gao Y; Chen Y; Wang S; Yang Y; Guo Q
    Anticancer Res; 2009 Jan; 29(1):411-7. PubMed ID: 19331180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI.
    Liang J; Dai W; Li Z; Liang X; Xiao M; Xie C; Li X
    BMC Cancer; 2022 Oct; 22(1):1033. PubMed ID: 36192709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endostar suppresses invasion through downregulating the expression of matrix metalloproteinase-2/9 in MDA-MB-435 human breast cancer cells.
    Lu N; Ling Y; Gao Y; Chen Y; Mu R; Qi Q; Liu W; Zhang H; Gu H; Wang S; Yang Y; Guo Q
    Exp Biol Med (Maywood); 2008 Aug; 233(8):1013-20. PubMed ID: 18480415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
    Deng G; Zhao DL; Li GC; Yu H; Teng GJ
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endostar, a recently introduced recombinant human endostatin, inhibits proliferation and migration through regulating growth factors, adhesion factors and inflammatory mediators in choroid-retinal endothelial cells.
    Xu W; Ye P; Li Z; Shi J; Wang W; Yao K
    Mol Biol (Mosk); 2010; 44(4):664-70. PubMed ID: 20873226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endostar inhibits hypoxia-induced cell proliferation and migration via the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in vitro.
    Lin K; Ye P; Liu J; He F; Xu W
    Mol Med Rep; 2015 May; 11(5):3780-5. PubMed ID: 25543905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic antiangiogenic activity of tetrandrine combined with Endostar on the human umbilical vein endothelial cell model.
    Qian X; Yan B; Zhou X; Xie L; Wei J; Li R; Yu L; Liu B
    Cancer Biother Radiopharm; 2013 Jun; 28(5):385-90. PubMed ID: 23682584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model.
    Xu X; Mao W; Chai Y; Dai J; Chen Q; Wang L; Zhuang Q; Pan Y; Chen M; Ni G; Huang Z
    J Atheroscler Thromb; 2015; 22(10):1100-12. PubMed ID: 26016418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.
    Cui Y; Liu H; Liang S; Zhang C; Cheng W; Hai W; Yin B; Wang D
    Oncotarget; 2016 May; 7(19):27243-54. PubMed ID: 27029065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differential anti-tumor effects for various regimens of endostar plus cisplatin in ovarian cancer].
    Xin G; Du J; Zhu L; Yu YH; Li Y; Liu PS
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(47):3367-70. PubMed ID: 22333207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling.
    Schmidt A; Wenzel D; Thorey I; Werner S; Fleischmann BK; Bloch W
    Endothelium; 2005; 12(5-6):251-7. PubMed ID: 16410224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endostar Rebuilding Vascular Homeostasis and Enhancing Chemotherapy Efficacy in Cervical Cancer Treatment.
    Guan L
    Onco Targets Ther; 2020; 13():12811-12827. PubMed ID: 33363386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of carboplatin plus paclitaxel combined with endostar against A375 melanoma cells: An in vitro and in vivo analysis.
    Zheng AW; Jia DD; Xia LM; Jin G; Wu H; Li T
    Biomed Pharmacother; 2016 Oct; 83():1321-1326. PubMed ID: 27571875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET imaging of neovascularization with (68)Ga-3PRGD2 for assessing tumor early response to Endostar antiangiogenic therapy.
    Shi J; Jin Z; Liu X; Fan D; Sun Y; Zhao H; Zhu Z; Liu Z; Jia B; Wang F
    Mol Pharm; 2014 Nov; 11(11):3915-22. PubMed ID: 25158145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical observation of Endostar® combined with chemotherapy in advanced colorectal cancer patients.
    Xu HX; Huang XE; Qian ZY; Xu X; Li Y; Li CG
    Asian Pac J Cancer Prev; 2011; 12(11):3087-90. PubMed ID: 22393994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.